{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T18:25:33Z","timestamp":1700159133068},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1994,3,1]],"date-time":"1994-03-01T00:00:00Z","timestamp":762480000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Adv Contracept"],"published-print":{"date-parts":[[1994,3]]},"DOI":"10.1007\/bf01986525","type":"journal-article","created":{"date-parts":[[2005,8,3]],"date-time":"2005-08-03T17:09:52Z","timestamp":1123088992000},"page":"19-26","source":"Crossref","is-referenced-by-count":3,"title":["Safety and efficacy of a combined oral contraceptive: Gestodene 75 \u03bcg plus ethinyl estradiol 30 \u03bcg in Mexican women"],"prefix":"10.1007","volume":"10","author":[{"given":"J.","family":"Garza-Flores","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. Valles","family":"de Bourges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"V\u00e1zquez-Estrada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Bassol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Recio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"P\u00e9rez-Palacios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01986525_CR1","unstructured":"Garza-Flores J, Mart\u00ednez M, D\u00edaz L, P\u00e9rez-Placios G. Risks and benefits of hormonal contraception. Oficina Sanitaria Panamericana; 1993."},{"key":"BF01986525_CR2","first-page":"781","volume":"36","author":"H Hofmeister","year":"1986","unstructured":"Hofmeister H, Annen K, Laurent H, Petzoldt K, Wiechert R. Synthesen von Gestodene. Arzneim-Foresch Drug Res. 1986;36:781\u20133.","journal-title":"Arzneim-Foresch Drug Res"},{"key":"BF01986525_CR3","unstructured":"Schering AG. Pharmacokinetic data on file."},{"issue":"suppl","key":"BF01986525_CR4","first-page":"6","volume":"32","author":"J Spona","year":"1987","unstructured":"Spona J, Huber J. Pharmacological and endocrine profiles of gestodene. Int J Fertil (suppl). 1987;32:6\u201314.","journal-title":"Int J Fertil"},{"key":"BF01986525_CR5","first-page":"45","volume-title":"Inhibition of ovulation with gestodene. Gestodene: Proceedings of a special satellite symposium held in conjunction with the XI World Congress of Gynecology and Obstetrics","author":"J Spona","year":"1987","unstructured":"Spona J, Huber J. Inhibition of ovulation with gestodene. Gestodene: Proceedings of a special satellite symposium held in conjunction with the XI World Congress of Gynecology and Obstetrics. Carnforth: Parthenon Publishing Group; 1987:45\u201354."},{"key":"BF01986525_CR6","unstructured":"Schering AG. Pharmacokinetics of gestodene, data on file."},{"key":"BF01986525_CR7","first-page":"459","volume":"35","author":"W Losert","year":"1985","unstructured":"Losert W et al. International experience with gestodene. Arzneim-Forsch. 1985;35:459.","journal-title":"Arzneim-Forsch"},{"issue":"suppl","key":"BF01986525_CR8","first-page":"29","volume":"32","author":"T Rabe","year":"1987","unstructured":"Rabe T, Runnebaum B, Kohlmeler, M, Harenberg J, Weicker H. Clinic and metabolic effects of gestodene and levonorgestrel. Int J Fertil (suppl) 1987;32:29\u201344.","journal-title":"Int J Fertil"},{"key":"BF01986525_CR9","first-page":"45","volume-title":"Un nuevo progest\u00e1geno espec\u00edfico para la anticoncepci\u00f3n oral a dosis bajas","author":"B D\u00fcsterberg","year":"1989","unstructured":"D\u00fcsterberg B, Brill K, M\u00fche B. El anticonceptivo oral monof\u00e1sico con gestodeno: revisi\u00f3n y resultados del programa mundial de ensayos cl\u00ednicos. In: Elstein M, ed. Un nuevo progest\u00e1geno espec\u00edfico para la anticoncepci\u00f3n oral a dosis bajas. Carnforth: Parthenon Publishing Group; 1989:45\u201355."},{"key":"BF01986525_CR10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0010-7824(87)90069-2","volume":"35","author":"K Fotherby","year":"1987","unstructured":"Fotherby K, Trayner I, Longtharne PN, Lee B, Watson HR. Metabolic investigations with Femodene, an oral contraceptive containing gestodene and ethinyl estradiol. Contraception. 1987;35:29\u201344.","journal-title":"Contraception"},{"key":"BF01986525_CR11","series-title":"Gestodene: Proceedings of a special satellite symposium held in conjunction with the XI World Congress of Gynecology and Obstetrics","first-page":"11","volume-title":"Metabolic effects of Femodene in new users, long term users and users switched from other oral contraceptives: an interim analysis","author":"P Bye","year":"1987","unstructured":"Bye P. Metabolic effects of Femodene in new users, long term users and users switched from other oral contraceptives: an interim analysis. Gestodene: Proceedings of a special satellite symposium held in conjunction with the XI World Congress of Gynecology and Obstetrics. Carnforth: Parthenon Publishing Group; 1987:11\u2013127."},{"key":"BF01986525_CR12","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI103182","volume":"34","author":"RJ Havel","year":"1955","unstructured":"Havel RJ et al. The distribution of chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955;34:1345.","journal-title":"J Clin Invest"},{"key":"BF01986525_CR13","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/B978-0-12-091304-6.50036-7","volume-title":"Methods of Enzymatic Analysis","author":"AW Walefeld","year":"1974","unstructured":"Walefeld AW. Triglycerides determination after enzymatic hydrolysis In: Bergmeyer HU, ed. Methods of Enzymatic Analysis. London: Verlag Chemie Weinheim and Academic Press. 1974:1831."},{"key":"BF01986525_CR14","first-page":"155","volume":"35","author":"DB Inversmit","year":"1950","unstructured":"Inversmit DB, Davis AK. Microdetermination of plasma phospholipids by trichloroacetic acid precipitation. J Lab Clin Med. 1950;35:155.","journal-title":"J Lab Clin Med."},{"key":"BF01986525_CR15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0015-0282(16)48681-4","volume":"44","author":"HA Hemer","year":"1985","unstructured":"Hemer HA, de Bourges VV, Ayala JJ, Brito G, D\u00edaz-S\u00e1nchez V, Garza-Flores J. Variations of serum lipid and lipoproteins throughout the menstrual cycle. Fertil Steril. 1985;44:80\u20134.","journal-title":"Fertil Steril"},{"key":"BF01986525_CR16","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/0002-9378(88)90200-1","volume":"158","author":"JC Rosa La","year":"1988","unstructured":"La Rosa JC. The varying effects of progestins on lipids levels and cardiovascular disease. Am J Obstet Gynecol. 1988;158:1621\u20139.","journal-title":"Am J Obstet Gynecol"},{"key":"BF01986525_CR17","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/0010-7824(88)90045-5","volume":"38","author":"WHO Task Force on Oral Contraceptives","year":"1988","unstructured":"WHO Task Force on Oral Contraceptives. A multicentre comparative study of serum lipids and lipoproteins in four groups of oral combined contraceptive users and a control group of IUD users. Contraception. 1988;38:605\u201329.","journal-title":"Contraception"},{"key":"BF01986525_CR18","first-page":"667","volume":"78","author":"KR Petersen","year":"1991","unstructured":"Petersen KR, Skouby SO, Pedersen RG. Desogestrel and gestodene in oral contraceptives: 12 months assessment of carbohydrate on lipoprotein metabolites. Obstet Gynecol. 1991;78:667\u201372.","journal-title":"Obstet Gynecol"},{"key":"BF01986525_CR19","first-page":"1034","volume":"81","author":"L Speroff","year":"1993","unstructured":"Speroff L, De Cherney A and the Advisory Board for the New Progestins. Evaluation of a new generation of oral contraceptives. Obstet Gynecol. 1993;81:1034\u201347.","journal-title":"Obstet Gynecol"}],"container-title":["Advances in Contraception"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01986525.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01986525\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01986525","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T21:38:29Z","timestamp":1557783509000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01986525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,3]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1994,3]]}},"alternative-id":["BF01986525"],"URL":"https:\/\/doi.org\/10.1007\/bf01986525","relation":{},"ISSN":["0267-4874","1573-7195"],"issn-type":[{"value":"0267-4874","type":"print"},{"value":"1573-7195","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,3]]}}}